midazolam has been researched along with doravirine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ancona, JK; Anderson, MS; Butterton, JR; Cilissen, C; De Lepeleire, I; Dockendorf, MF; Gilmartin, J; Guo, Y; Liu, R; Tetteh, E; Van Bortel, L; Wagner, JA | 1 |
1 trial(s) available for midazolam and doravirine
Article | Year |
---|---|
Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects.
Topics: Adult; Area Under Curve; Chromatography, Liquid; Cytochrome P-450 CYP3A; Double-Blind Method; Drug Administration Schedule; Half-Life; Healthy Volunteers; Humans; Male; Midazolam; Middle Aged; Pyridones; Reverse Transcriptase Inhibitors; Tandem Mass Spectrometry; Triazoles | 2015 |